Related references
Note: Only part of the references are listed.Overcalling low-risk findings: grouped amorphous calcifications found at screening mammography associated with minimal cancer risk
Madoka Iwase et al.
BREAST CANCER (2017)
More misinformation on breast cancer screening
Daniel B. Kopans
GLAND SURGERY (2017)
Variability in Pathologists' Interpretations of Individual Breast Biopsy Slides: A Population Perspective
Joann G. Elmore et al.
ANNALS OF INTERNAL MEDICINE (2016)
Patient Prognostic Score and Associations With Survival Improvement Offered by Radiotherapy After Breast-Conserving Surgery for Ductal Carcinoma In Situ: A Population-Based Longitudinal Cohort Study
Yasuaki Sagara et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Anastrozole versus tamoxifen for the prevention of locoregional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ (IBIS-II DCIS): a double-blind, randomised controlled trial
John F. Forbes et al.
LANCET (2016)
Breast-Cancer Tumor Size, Overdiagnosis, and Mammography Screening Effectiveness
H. Gilbert Welch et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Tamoxifen Initiation After Ductal Carcinoma In Situ
Hazel B. Nichols et al.
ONCOLOGIST (2016)
Molecular phenotypes of DCIS predict overall and invasive recurrence
K. E. Williams et al.
ANNALS OF ONCOLOGY (2015)
Risk of subsequent in situ and invasive breast cancer in human epidermal growth factor receptor 2-positive ductal carcinoma in situ
G. Curigliano et al.
ANNALS OF ONCOLOGY (2015)
Population-based analysis of the impact and generalizability of the NSABP-B24 study on endocrine therapy for patients with ductal carcinoma in situ of the breast
A. C. Lo et al.
ANNALS OF ONCOLOGY (2015)
A population-based validation study of the DCIS Score predicting recurrence risk in individuals treated by breast-conserving surgery alone
Eileen Rakovitch et al.
BREAST CANCER RESEARCH AND TREATMENT (2015)
NSABP B-43 is unlikely to produce a cost-effective treatment strategy for HER2+DCIS
Michael D. Alvarado et al.
CANCER RESEARCH (2015)
A Molecular Portrait of High-Grade Ductal Carcinoma In Situ
Martin C. Abba et al.
CANCER RESEARCH (2015)
Addressing overtreatment of screen detected DCIS; the LORIS trial
Adele Francis et al.
EUROPEAN JOURNAL OF CANCER (2015)
RTOG 9804: A Prospective Randomized Trial for Good-Risk Ductal Carcinoma In Situ Comparing Radiotherapy With Observation
Beryl McCormick et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Survival Benefit of Breast Surgery for Low-Grade Ductal Carcinoma In Situ A Population-Based Cohort Study
Yasuaki Sagara et al.
JAMA SURGERY (2015)
Addressing overdiagnosis and overtreatment in cancer: a prescription for change
Laura J. Esserman et al.
LANCET ONCOLOGY (2014)
Molecular effects of lapatinib in patients with HER2 positive ductal carcinoma in situ
Laura G. Estevez et al.
BREAST CANCER RESEARCH (2014)
Influence of Study Features and Methods on Overdiagnosis Estimates in Breast and Prostate Cancer Screening
Ruth Etzioni et al.
ANNALS OF INTERNAL MEDICINE (2013)
Preliminary results of centralized HER2 testing in ductal carcinoma in situ (DCIS): NSABP B-43
Kalliopi P. Siziopikou et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
A Multigene Expression Assay to Predict Local Recurrence Risk for Ductal Carcinoma In Situ of the Breast
Lawrence J. Solin et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)
Predictors of recurrence for ductal carcinoma in situ after breast-conserving surgery
John R. Benson et al.
LANCET ONCOLOGY (2013)
Effect of Three Decades of Screening Mammography on Breast-Cancer Incidence
Archie Bleyer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Tumor characteristics as predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis
Shi-Yi Wang et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Impact of mammographic screening on the detection of good and poor prognosis breast cancers
Laura J. Esserman et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Characterizing the impact of 25 years of DCIS treatment
Elissa M. Ozanne et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Molecular subtyping of DCIS: heterogeneity of breast cancer reflected in pre-invasive disease
S. E. Clark et al.
BRITISH JOURNAL OF CANCER (2011)
Long-Term Outcomes of Invasive Ipsilateral Breast Tumor Recurrences After Lumpectomy in NSABP B-17 and B-24 Randomized Clinical Trials for DCIS
Irene L. Wapnir et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trial
Jack Cuzick et al.
LANCET ONCOLOGY (2011)
Preinvasive Breast Cancer
Dennis C. Sgroi
ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE (2010)
National Institutes of Health State-of-the-Science Conference Statement: Diagnosis and Management of Ductal Carcinoma In Situ September 22-24, 2009
Carmen J. Allegra et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
Ductal Carcinoma In Situ of the Breast: A Systematic Review of Incidence, Treatment, and Outcomes
Beth A. Virnig et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
Rethinking Screening for Breast Cancer and Prostate Cancer
Laura Esserman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Local Excision Alone Without Irradiation for Ductal Carcinoma In Situ of the Breast: A Trial of the Eastern Cooperative Oncology Group
Lorie L. Hughes et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Overdiagnosis in publicly organised mammography screening programmes: systematic review of incidence trends
Karsten Juhl Jorgensen et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
Rationalization and regionalization of treatment for ductal carcinoma in situ of the breast
Grace L. Smith et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2006)
Share Paper
